health pharma news today obesity drugs glp-1 A new oral option is now part of medicine. FDA approved Foundayo (orforglipron), a once-daily oral GLP-1 receptor agonist, for adults with obesity or overweight with at least one weight-related Weight loss with GLP-1 medicines

You may notice mild redness at the injection site for a few hours

The rapid onset of benefit from SGLT2 inhibitors suggests that haemodynamic and metabolic improvements, rather than structural reverse remodelling, drive early risk reduction

Authentic Relumins Meso Revitalizing Holiday Gift Set Revitalize your skin this season with this new Meso set

This guide covers the biochemistry that answers "is HCG a peptide," what the hormone actually does in the body, its legitimate uses in fertility and men's health, its role alongside testosterone therapy, and why the weight-loss version is a myth the FDA has already knocked down

Research shows that L-carnitine supplementation produces modest metabolic benefits in certain populations, particularly those with documented deficiency